ICMR: Guidance for Management of Pregnant Women in COVID-19 Pandemic

A male Age :6 years. What should be the probable cause of Mesentric lymphandenitis?

Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women Background Previous studies on the pneumonia outbreak caused by the 2019 novel coronavirus disease (COVID-19) were based on information from the general population. Limited data are available for pregnant women with COVID-19 pneumonia. This study aimed to evaluate the clinical characteristics of COVID-19 in pregnancy and the intrauterine vertical transmission potential of COVID-19 infection. Methods Clinical records, laboratory results, and chest CT scans were retrospectively reviewed for nine pregnant women with laboratory-confirmed COVID-19 pneumonia (ie, with maternal throat swab samples that were positive for severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) who were admitted to Zhongnan Hospital of Wuhan University, Wuhan, China, from Jan 20 to Jan 31, 2020. Evidence of intrauterine vertical transmission was assessed by testing for the presence of SARS-CoV-2 in amniotic fluid, cord blood, and neonatal throat swab samples. Breastmilk samples were also collected and tested from patients after the first lactation. Findings All nine patients had a caesarean section in their third trimester. Seven patients presented with a fever. Other symptoms, including cough (in four of nine patients), myalgia (in three), sore throat (in two), and malaise (in two), were also observed. Fetal distress was monitored in two cases. Five of nine patients had lymphopenia (<1·0 × 10⁹ cells per L). Three patients had increased aminotransferase concentrations. None of the patients developed severe COVID-19 pneumonia or died, as of Feb 4, 2020. Nine livebirths were recorded. No neonatal asphyxia was observed in newborn babies. All nine livebirths had a 1-min Apgar score of 8–9 and a 5-min Apgar score of 9–10. Amniotic fluid, cord blood, neonatal throat swab, and breastmilk samples from six patients were tested for SARS-CoV-2, and all samples tested negative for the virus. Interpretation The clinical characteristics of COVID-19 pneumonia in pregnant women were similar to those reported for non-pregnant adult patients who developed COVID-19 pneumonia. Findings from this small group of cases suggest that there is currently no evidence for intrauterine infection caused by vertical transmission in women who develop COVID-19 pneumonia in late pregnancy. To read more- https://www.sciencedirect.com/science/article/pii/S0140673620303603 Source-sciencedirect

Please suggest treatment regarding swelling in the axillary area.. A 20 years old unmarried girl having swelling in both the axillary areas since 15 years.. Soft, mild tenderness+. Both the breasts totally normal. No history of any injury in the past or present. Menstrual cycles are also regular.

34yrs/M admitted with C/o Generalized bodyaches,3 day history of on and off fever which is temporarily relieved by paracetamol,Hypogastric pain,He also experienced nausea and vomitting with loss of appetite.NO PETECHIAE OR RASES present over body.He was tested negative for COVID 19 but positive for dengue.On day 2 admission patient developed dry cough and mild difficulty in breathing. NEED SUGGESTIONS? *Chief Complaints* Fever,bodyaches,NV, Abdomen pain *History* No relevant medical history *Vitals* BP - 120/80,HR -110,Temp -99°F,Spo2 -98% without O2 support,RR - 18 *Investigations* COVID - RT PCR - NEGATIVE DENGUE IGg - Positive Platelet counts -4000,Hb -12,TLC -12000 HRCT chest enclosed

UNCOMMON MANIFESTATIONS of COVID-19 Recent findings suggest that a significant number of people with COVID-19 may experience digestive symptoms. New research data says that out of all the patients who approached for medical care half of them have come up with the symptoms of the digestive system, such as loss of appetite and diarrhea. As the world races to find the best ways to cope with the new coronavirus, researchers continue to contribute to our understanding of COVID-19, the disease that the virus causes. The exact symptoms are the main point of interest. As with many other viral infections, SARS-CoV-2 infections cause different symptoms in different people. But WHICH SYMPTOMS ARE THE MOST COMMON? According to information from the World Health Organization (WHO), three of the most common symptoms are fever, coughing, and some difficulty breathing. However, people with COVID-19 have reported many other symptoms, including digestive ones. While the WHO still consider digestive symptoms to be uncommon, a new study from the Wuhan Medical Treatment Expert Group for COVID-19 suggests that such symptoms may be more widespread than specialists had thought. Digestive symptoms in 50.5% of patients were observed. The expert group behind this new study — the findings of which appear in The American Journal of Gastroenterology — analyzed data from 204 people who received medical care for COVID-19 between January 18 and February 28, 2020. The patients had an average age of 52.9 years, and of the total, 107 were male and 97 female. When they presented to a hospital, 103 of the 204 people — or 50.5% — were experiencing digestive symptoms. The main symptom reported was diarrhea, and other symptoms included vomiting, in four individuals, and abdominal pain, in two. Moreover, the digestive symptoms among the larger group grew more severe as the severity of COVID-19 increased the researchers' report.